Home UniQure Deal Confirms Red-Hot Interest In Advanced Therapies
 

Keywords :   


UniQure Deal Confirms Red-Hot Interest In Advanced Therapies

2015-04-08 03:15:03| Trucking - Topix.net

If there is any sign that pharma is beating the bushes to flush out promising advanced therapies, it is that Bristol-Myers For a near-term outlay of nearly $100m, Bristol-Myers gets the heart failure candidate AAV-S100A1 and three other targets. Along with Bluebird Bio , Celladon and Voyager Therapeutics, UniQure shows that gene therapy has begun a modest but noteworthy renaissance.

Tags: advanced interest deal confirms

Category:Transportation and Logistics

Latest from this category

All news

24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
Transportation and Logistics »
24.11
24.113DSLL
24.11
24.11
24.11
24.11logicool flight switch panel
24.11Z
24.11 126
More »